Balancing these tools with operational efficiencies can aid CROs in meeting the evolving needs of sponsors.
Guillaume Gigon
Advertisement
VP of Technology and AI, Innovaderm
Articles by Guillaume Gigon
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
2
From Participation to Understanding: Reframing Engagement in Clinical Trials
3
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
4
ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis
5